UNSPSC 85819103: Transfusion of autologous cord blood stem cells into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous cord blood stem cells into peripheral artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30253X0

UNSPSC 85819103 Transfusion of autologous cord blood stem cells into peripheral artery, percutaneous approach is a Commodity code that shows little recent state and local procurement activity aligned with its nominal scope. The recent opportunities tagged under this code—independent medical evaluations for pension disability determinations, surgical benefits carve-out programs, occupational medical surveillance, juvenile detention healthcare services, pharmacy benefit management, and temporary health professional staffing—address general medical services administration and personnel placement rather than stem-cell therapies or transfusion procedures. State and local governments do not appear to be soliciting stem-cell transfusion services under this code currently. The mismatch between the code's technical clinical definition and the work actually being purchased suggests either systematic miscoding in source systems or that this code's application domain does not align with mainstream state and local procurement activity.

The issuing bodies in the recent block span diverse jurisdictions: city retirement offices (Phoenix), municipal HR departments (Long Beach), state transportation agencies (Washington Department of Transportation), county juvenile probation (Harris County), county health systems (Collier County, Santa Clara County), and health-system consortiums. Geographic distribution includes Arizona, California, Florida, Texas, and Washington. No single issuer or state appears more than once in the recent opportunity set, and no procurement body demonstrates repeat activity under this code. Given the code's narrow clinical specification and the absence of aligned solicitations, this code does not present a clear business development opportunity for vendors seeking state and local contracts.